Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies. Homology Medicines is utilizing a platform that enables highly efficient homologous recombination-based in vivo genomic correction of disease mutations or precise insertion of therapeutic sequences. Homology has licensed a novel AAV technology from Caltech for developing treatments for rare CNS disorders. NASDAQ: FIXX